Home/Alveron Pharma/Michel Briejer

MB

Michel Briejer

Supervisory Board Member

Therapeutic Areas

Hematology Neurology Cardiovascular

Alveron Pharma Pipeline

Drug	Indication	Phase
OKL-1111	Anticoagulant reversal for Hemorrhagic Stroke / Intracranial Hemorrhage (ICH)	Pre-clinical

Leadership Team at Alveron Pharma

Chief Executive Officer

Chief Operating Officer

Chief Development Officer

View full Alveron Pharma profile